Therapeutic Effects of Silibinin Against Polycystic Ovary Syndrome Induced by Letrozole in Rats via Its Potential Anti-Inflammatory and Anti-Oxidant Activities

BACKGROUND: Current therapies for polycystic ovary syndrome (PCOS) are accompanied by unwanted effects. Silibinin; a flavonolignan has pleiotropic activities and favorable safety profile. PURPOSE: To investigate the efficacy of silibinin on estrous cyclicity, inflammation, oxidative stress and ovari...

Descripción completa

Detalles Bibliográficos
Autores principales: Marouf, Bushra Hassan, Ismaeel, Dana Omer, Hassan, Ali Hussein, Ali, Othman Jalal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469941/
https://www.ncbi.nlm.nih.gov/pubmed/36110507
http://dx.doi.org/10.2147/JIR.S379725

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469941/
https://www.ncbi.nlm.nih.gov/pubmed/36110507
http://dx.doi.org/10.2147/JIR.S379725

Ejemplares similares